Low platelet mitochondrial complex I and complex II/III activity in early untreated parkinson's disease

PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT

Lowry, O. H., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 315,771 · see citing works

Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog Synthesis

Langston, J. W., Ballard, P., Tetrud, J. W., & Irwin, I. (1983) · Science · doi:10.1126/science.6823561 · Cited by 4,914 · see citing works

Mitochondrial Complex I Deficiency in Parkinson's Disease

Schapira, A. H. V., Cooper, J. M., Dexter, D., Clark, J. B., Jenner, P., & Marsden, C. D. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb02325.x · Cited by 2,283 · see citing works

MITOCHONDRIAL COMPLEX I DEFICIENCY IN PARKINSON'S DISEASE

Schapira, A. H. V., Cooper, J. A. D., Dexter, D. T., Jenner, P. G., Clark, J. B., & MARSDEN, C. D. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92366-0 · Cited by 1,757 · see citing works

Abnormalities of the electron transport chain in idiopathic parkinson's disease

Parker, W. D., Boyson, S. J., & Parks, J. K. (1989) · Annals of Neurology · doi:10.1002/ana.410260606 · Cited by 1,061 · see citing works

Oxidative damage to mitochondrial DNA shows marked age-dependent increases in human brain

Mecocci, P., MacGarvey, U., Kaufman, A. E., Koontz, D., Shoffner, J. M., Wallace, D. C., & Beal, M. F. (1993) · Annals of Neurology · doi:10.1002/ana.410340416 · Cited by 757 · see citing works

CENTRAL CERVICAL CORD SYNDROME AFTER HEADING A FOOTBALL

Scoppetta, C., & Vaccario, M. L. (1978) · The Lancet · doi:10.1016/s0140-6736(78)92517-5 · Cited by 755 · see citing works

Deficiencies in Complex I subunits of the respiratory chain in Parkinson's disease

Mizuno, Y., Ohta, S., Tanaka, M., Takamiya, S., Suzuki, K., SATO, T. A., Oya, H., Ozawa, T., & Kagawa, Y. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)91141-8 · Cited by 735 · see citing works

Spectrophotometric Assay of Cytochrome c Oxidase

Smith, L. (1955) · Methods of biochemical analysis · doi:10.1002/9780470110188.ch13 · Cited by 506 · see citing works

Mitochondrial DNA Variants Observed in Alzheimer Disease and Parkinson Disease Patients

Shoffner, J. M., Brown, M. D., Torroni, A., Lott, M. T., Cabell, M. F., Mirra, S. S., Beal, M. F., Yang, C.-C., Gearing, M., Salvo, R., et al. (1993) · Genomics · doi:10.1006/geno.1993.1299 · Cited by 450 · see citing works

[2] Citrate synthase from rat liver

Shepherd, D., & Garland, P. B. (1969) · Methods in Enzymology · doi:10.1016/0076-6879(69)13006-2 · Cited by 434 · see citing works

Platelet mitochondria function in Parkinson's disease

Krige, D., Carroll, M. T., Cooper, J. A. D., MARSDEN, C. D., & Schapira, A. H. V. (1992) · Annals of Neurology · doi:10.1002/ana.410320612 · Cited by 358 · see citing works

Parkinson's disease in 65 pairs of twins and in a set of quadruplets

Ward, C. D., Duvoisin, R. C., Ince, S. E., Nutt, J., Eldridge, R., & Calne, D. B. (1983) · Neurology · doi:10.1212/wnl.33.7.815 · Cited by 347 · see citing works

BRAIN, SKELETAL MUSCLE AND PLATELET HOMOGENATE MITOCHONDRIAL FUNCTION IN PARKINSON'S DISEASE

MANN, V. M., COOPER, J. M., KRIGE, D., DANIEL, S. E., SCHAPIRA, A. H. V., & MARSDEN, C. D. (1992) · Brain · doi:10.1093/brain/115.2.333 · Cited by 346 · see citing works

Increase of deleted mitochondrial DNA in the striatum in Parkinson's disease and senescence

Ikebe, S.-I., Tanaka, M., Ohno, K., Sato, W., Hattori, K., Kondo, T., Mizuno, Y., & Ozawa, T. (1990) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(90)90497-b · Cited by 341 · see citing works

Mitochondrial oxidative phosphorylation defects in parkinson's disease

Shoffner, J. M., Watts, R. L., Juncos, J. L., Torroni, A., & Wallace, D. C. (1991) · Annals of Neurology · doi:10.1002/ana.410300304 · Cited by 333 · see citing works

Risk factors for Parkinson's disease

Hubble, J. P., Cao, T., Hassanein, R. E. S., Neuberger, J. S., & Roller, W. C. (1993) · Neurology · doi:10.1212/wnl.43.9.1693 · Cited by 279 · see citing works

Immunohistochemical studies on complexes I, II, III, and IV of mitochondria in parkinson's disease

Hattori, N., Tanaka, M., Ozawa, T., & Mizuno, Y. (1991) · Annals of Neurology · doi:10.1002/ana.410300409 · Cited by 275 · see citing works

MITOCHONDRIAL FUNCTION IN PARKINSON'S DISEASE

Bindoff, L. A., Birch‐Machin, M. A., Cartlidge, N. E. F., Parker, W. D., & Turnbull, D. M. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90291-2 · Cited by 245 · see citing works

Biochemical Events in the Development of Parkinsonism Induced by 1‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine

Singer, T. P., Castagnoli, N., Ramsay, R. R., & Trevor, A. J. (1987) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1987.tb03384.x · Cited by 244 · see citing works

Respiratory chain abnormalities in skeletal muscle from patients with Parkinson's disease

Bindoff, L. A., Birch‐Machin, M. A., Cartlidge, N. E. F., Parker, W. D., & Turnbull, D. M. (1991) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(91)90311-t · Cited by 229 · see citing works

Neuroleptic medications inhibit complex I of the electron transport chain

Burkhardt, C., Kelly, J. P., Lim, Y., Filley, C. M., & Parker, W. D. (1993) · Annals of Neurology · doi:10.1002/ana.410330516 · Cited by 221 · see citing works

Electron transfer complexes I and IV of platelets are abnormal in Parkinson's disease but normal in Parkinson-plus syndromes

Benecke, R., Strumper, P., & Weiss, H. (1993) · Brain · doi:10.1093/brain/116.6.1451 · Cited by 220 · see citing works

Evidence for mitochondrial dysfunction in Parkinson's disease—a critical appraisal

Schapira, A. H. V. (1994) · Movement Disorders · doi:10.1002/mds.870090202 · Cited by 218 · see citing works

Unaltered aconitase activity, but decreased complex I activity in substantia nigra pars compacta of patients with Parkinson's disease

Janetzky, B., Hauck, S., Youdim, M. B. H., Riederer, P. F., Jellinger, K. A., Pantucek, F., ̈chling, R. Z., Boissl, K. W., & Reichmann, H. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90372-7 · Cited by 206 · see citing works

An endogenous substance of the brain, tetrahydroisoquinoline, produces parkinsonism in primates with decreased dopamine, tyrosine hydroxylase and biopterin in the nigrostriatal regions

Nagatsu, T., & Yoshida, M. (1988) · Neuroscience Letters · doi:10.1016/0304-3940(88)90166-8 · Cited by 198 · see citing works

Mitochondrial complex I and II activities of lymphocytes and platelets in Parkinson's disease

Yoshino, H., Nakagawa-Hattori, Y., Kondo, T., & Mizuno, Y. (1992) · Journal of Neural Transmission - Parkinsons Disease and Dementia Section · doi:10.1007/bf02257619 · Cited by 195 · see citing works

[3] Preparation and properties of NADH: Ubiquinone oxidoreductase (complex I), EC 1.6.5.3

Hatefi, Y. (1978) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(78)53006-1 · Cited by 194 · see citing works

Quantitative determination of deleted mitochondrial DNA relative to normal DNA in parkinsonian striatum by a kinetic PCR analysis

Ozawa, T., Tanaka, M., Ikebe, S.-I., Ohno, K., Kondo, T., & Mizuno, Y. (1990) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(90)90698-m · Cited by 187 · see citing works

Ecogenetics of Parkinson's Disease: Prevalence and Environmental Aspects in Rural Areas

Barbeau, A., Roy, M., Bernier, G. P., Campanella, G., & Paris, S. (1987) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100026147 · Cited by 174 · see citing works

Chronic levodopa administration alters cerebral mitochondrial respiratory chain activity

Przedborski, S., Jackson-Lewis, V. R., Muthane, U. B., Jiang, H., Ferreira, M., Naini, A., & Fahn, S. (1993) · Annals of Neurology · doi:10.1002/ana.410340515 · Cited by 149 · see citing works

A clinical genetic study of Parkinson's disease

Lazzarini, A. M., Myers, R. H., Zimmerman, T. R., Mark, M. H., Golbe, L. I., Sage, J. I., Johnson, W. G., & Duvoisin, R. C. (1994) · Neurology · doi:10.1212/wnl.44.3_part_1.499 · Cited by 137 · see citing works

Normal Mitochondrial Genome in Brain from Patients with Parkinson's Disease and Complex I Defect

Lestienne, P. P., Nelson, J., Riederer, P. F., Jellinger, K. A., & Reichmann, H. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb04973.x · Cited by 129 · see citing works

Postmortem changes in mitochondrial respiratory enzymes in brain and a preliminary observation in Parkinson's disease

Mizuno, Y., Suzuki, K., & Ohta, S. (1990) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(90)90056-s · Cited by 129 · see citing works

Biochemical mechanism of action of the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)

Sayre, L. M. (1989) · Toxicology Letters · doi:10.1016/0378-4274(89)90168-9 · Cited by 115 · see citing works

Fatal Lactic Acidosis in Infancy with a Defect of Complex III of the Respiratory Chain

Birch‐Machin, M. A., Shepherd, I. M., Watmough, N. J., Sherratt, H. S. A., Bartlett, K., Darley-Usmar, V. M., Milligan, D. W. A., Welch, R. J., Aynsley-Green, A., & Turnbull, D. M. (1989) · Pediatric Research · doi:10.1203/00006450-198905000-00025 · Cited by 106 · see citing works

Methods for Study of Normal and Abnormal Skeletal Muscle Mitochondria

Sherratt, H. S. A., Watmough, N. J., Johnson, M. A., & Turnbull, D. M. (1988) · Methods of biochemical analysis · doi:10.1002/9780470110546.ch6 · Cited by 93 · see citing works

Energy metabolism of blood platelets

Salganicoff, L., & Fukami, M. H. (1972) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(72)90391-8 · Cited by 49 · see citing works

The biochemical basis of neuropharmacology

Bruyn, G. W. (1987) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(87)90245-0 · Cited by 47 · see citing works

Effect of aging and dopaminomimetic therapy on mitochondrial respiratory function in Parkinson's disease

Bravi, D., Anderson, J. J., Dagani, F., Davis, T. L., Ferrari, R., Gillespie, M., & Chase, T. N. (1992) · Movement Disorders · doi:10.1002/mds.870070307 · Cited by 43 · see citing works

No evidence for altered muscle mitochondrial function in Parkinson's disease.

Anderson, J. J., Bravi, D., Ferrari, R., Davis, T. L., Baronti, F., Chase, T. N., & Dagani, F. (1993) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.56.5.477 · Cited by 39 · see citing works

Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-like compounds on mitochondrial respiration.

Suzuki, K., Mizuno, Y., & Yoshida, M. (1990) · PubMed · Cited by 37 · see citing works

Subcellular fractionation of pig platelets

Salganicoff, L., Hebda, P. A., Yandrasitz, J. R., & Fukami, M. H. (1975) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(75)90369-4 · Cited by 34 · see citing works

Human mitochondrial electron transport chain: Assay of succinate:Cytochrome c reductase in leukocytes, platelets and cultured fibroblasts

Stumpf, D. A., & Parks, J. K. (1981) · Biochemical Medicine · doi:10.1016/0006-2944(81)90080-6 · Cited by 33 · see citing works

PCR Analysis of platelet mtDNA: Lack of specific changes in Parkinson's disease

Sandy, M. S., Langston, J. W., Smith, M. T., & Monte, D. A. D. (1993) · Movement Disorders · doi:10.1002/mds.870080114 · Cited by 32 · see citing works

Selective inhibition of complex I of the brain electron transport system by tetrahydroisoquinoline

Suzuki, K., Mizuno, Y., & Yoshida, M. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)90850-4 · Cited by 28 · see citing works

Monozygotic twins with Parkinson's disease

Koller, W. C., O'Hara, R., Nutt, J., Young, J. D., & Rubino, F. A. (1986) · Annals of Neurology · doi:10.1002/ana.410190420 · Cited by 15 · see citing works

Parkinson's Disease

Lang, A. E., & Lozano, A. M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810083391506 · Cited by 2,041 · see citing works

Mechanism of Toxicity in Rotenone Models of Parkinson's Disease

Sherer, T., Betarbet, R. S., Testa, C. M., Seo, B. B., Richardson, J. R., Kim, J. H., Miller, G. W., Yagi, T., Matsuno‐Yagi, A., & Greenamyre, J. T. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-34-10756.2003 · Cited by 1,073 · see citing works

Effects of Coenzyme Q10 in Early Parkinson Disease: Evidence of Slowing of the Functional Decline

Shults, C. W. (2002) · Archives of Neurology · doi:10.1001/archneur.59.10.1541 · Cited by 984 · see citing works

Mitochondrial dysfunction and oxidative stress in Parkinson's disease

Subramaniam, S., & Chesselet, M. (2013) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.04.004 · Cited by 925 · see citing works

Mitochondria in the aetiology and pathogenesis of Parkinson's disease

Schapira, A. H. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70327-7 · Cited by 883 · see citing works

Oxidative stress and Parkinson’s disease

Blesa, J., Trigo-Damas, I., Quiroga-Varela, A., & Jackson-Lewis, V. R. (2015) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2015.00091 · Cited by 878 · see citing works

PGC-1 α, A Potential Therapeutic Target for Early Intervention in Parkinson’s Disease

Zheng, B., Liao, Z., Locascio, J. J., Lesniak, K. A., Roderick, S. S., Watt, M. L., Eklund, A. C., Zhang‐James, Y., Kim, P. D., Hauser, M. A., et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3001059 · Cited by 854 · see citing works

Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis

Henchcliffe, C., & Beal, M. F. (2008) · Nature Clinical Practice Neurology · doi:10.1038/ncpneuro0924 · Cited by 786 · see citing works

Subcutaneous Rotenone Exposure Causes Highly Selective Dopaminergic Degeneration and α-Synuclein Aggregation

Sherer, T., Kim, J.-H., Betarbet, R. S., & Greenamyre, J. T. (2002) · Experimental Neurology · doi:10.1006/exnr.2002.8072 · Cited by 707 · see citing works

Loss of PINK1 causes mitochondrial functional defects and increased sensitivity to oxidative stress

Gautier, C. A., Kitada, T., & Shen, J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802076105 · Cited by 698 · see citing works

Mitochondrial dysfunction in Parkinson's disease

Winklhofer, K. F., & Haass, C. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.08.013 · Cited by 688 · see citing works

Origin and functional consequences of the complex I defect in Parkinson's disease

Swerdlow, R. H., Parks, J. K., Miller, S. W., Davis, R. E., Tuttle, J. B., Trimmer, P. A., Sheehan, J. P., Bennett, J. P., & Parker, W. D. (1996) · Annals of Neurology · doi:10.1002/ana.410400417 · Cited by 638 · see citing works

What Genetics Tells us About the Causes and Mechanisms of Parkinson's Disease

Corti, O., Lesage, S., & Brice, A. (2011) · Physiological Reviews · doi:10.1152/physrev.00022.2010 · Cited by 610 · see citing works

D-β-Hydroxybutyrate rescues mitochondrial respiration and mitigates features of Parkinson disease

Tieu, K., Perier, C., Caspersen, C., Teismann, P., Wu, D.-C., Yan, S.-D., Naini, A., Vila, M., Jackson-Lewis, V., Ramasamy, R., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200318797 · Cited by 497 · see citing works

Lewy bodies

Shults, C. W. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509567103 · Cited by 476 · see citing works

A randomized, double-blind, futility clinical trial of creatine and minocycline in early Parkinson disease

The NINDS NET-PD Investigators (2006) · Neurology · doi:10.1212/01.wnl.0000201252.57661.e1 · Cited by 453 · see citing works

The MPTP Story

Langston, J. W. (2017) · Journal of Parkinson s Disease · doi:10.3233/jpd-179006 · Cited by 424 · see citing works

Mitochondrial Diseases of the Brain

Chaturvedi, R. K., & Beal, M. F. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.03.018 · Cited by 416 · see citing works

Metabolomic profiling to develop blood biomarkers for Parkinson's disease

Bogdanov, M. B., Matson, W. R., Wang, L., Matson, T., Saunders-Pullman, R. J., Bressman, S., & Beal, M. F. (2008) · Brain · doi:10.1093/brain/awm304 · Cited by 402 · see citing works

Glutathione, iron and Parkinson’s disease

Bharath, S., Hsu, M., Kaur, D., Rajagopalan, S., & Andersen, J. K. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01174-7 · Cited by 394 · see citing works

Complex I deficiency in Parkinson's disease frontal cortex

Parker, W. D., Parks, J. K., & Swerdlow, R. H. (2007) · Brain Research · doi:10.1016/j.brainres.2007.10.061 · Cited by 383 · see citing works

The Role of Mitochondria in Neurodegenerative Diseases: the Lesson from Alzheimer’s Disease and Parkinson’s Disease

Monzio Compagnoni, G., Di Fonzo, A., Corti, S., Comi, G. P., Bresolin, N., & Masliah, E. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-01926-1 · Cited by 378 · see citing works

Mitochondria in Neurodegeneration: Acute Ischemia and Chronic Neurodegenerative Diseases

Fiskum, G. M., Murphy, A. N., & Beal, M. F. (1999) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199904000-00001 · Cited by 351 · see citing works

Mechanism of toxicity of pesticides acting at complex I: relevance to environmental etiologies of Parkinson’s disease

Sherer, T., Richardson, J. R., Testa, C. M., Seo, B. B., Panov, A. V., Yagi, T., Matsuno‐Yagi, A., Miller, G. W., & Greenamyre, J. T. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04333.x · Cited by 339 · see citing works

Complex I and Parkinson's Disease

Greenamyre, J. T., Sherer, T., Betarbet, R. S., & Panov, A. V. (2001) · IUBMB Life · doi:10.1080/15216540152845939 · Cited by 335 · see citing works

Damage to dopaminergic neurons by oxidative stress in Parkinson's disease (Review)

Guo, J., Zhao, X., Li, Y., Li, G., & Liu, X. (2018) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2018.3406 · Cited by 347 · see citing works

Mitochondria and Quality Control Defects in a Mouse Model of Gaucher Disease—Links to Parkinson’s Disease

Osellame, L. D., Rahim, A. A., Hargreaves, I. P., Gegg, M. E., Richard-Loendt, A., Brandner, S., Waddington, S. N., Schapira, A. H. V., & Duchen, M. R. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.04.014 · Cited by 329 · see citing works

Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson's disease

Büeler, H. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.03.006 · Cited by 326 · see citing works

Coenzyme Q₁₀ levels correlate with the activities of complexes I and II/III in mitochondria from parkinsonian and nonparkinsonian subjects

Shults, C. W., Haas, R. H., Passov, D., & Beal, M. F. (1997) · Annals of Neurology · doi:10.1002/ana.410420221 · Cited by 326 · see citing works

Mitochondrial DNA transmission of the mitochondrial defect in Parkinson's disease

Gu, M., Cooper, J. A. D., Taanman, J., & Schapira, A. H. V. (1998) · Annals of Neurology · doi:10.1002/ana.410440207 · Cited by 313 · see citing works

The Role of Mitochondria in Reactive Oxygen Species Generation and Its Implications for Neurodegenerative Diseases

Kausar, S., Wang, F., & Cui, H. (2018) · Cells · doi:10.3390/cells7120274 · Cited by 315 · see citing works

Mitochondrial involvement in Parkinson’s disease, Huntington’s disease, hereditary spastic paraplegia and Friedreich’s ataxia

Schapira, A. H. V. (1999) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/s0005-2728(98)00164-9 · Cited by 310 · see citing works

Rotenone induces oxidative stress and dopaminergic neuron damage in organotypic substantia nigra cultures

Testa, C. M., Sherer, T., & Greenamyre, J. T. (2005) · Molecular Brain Research · doi:10.1016/j.molbrainres.2004.11.007 · Cited by 296 · see citing works

Enhanced substantia nigra mitochondrial pathology in human α-synuclein transgenic mice after treatment with MPTP111-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine.

Song, D. D., Shults, C. W., Sisk, A., Rockenstein, E. M., & Masliah, E. (2003) · Experimental Neurology · doi:10.1016/s0014-4886(03)00342-x · Cited by 294 · see citing works

Mitochondrial Approaches for Neuroprotection

Chaturvedi, R. K., & Beal, M. F. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1427.027 · Cited by 294 · see citing works

The rotenone model of Parkinson's disease: genes, environment and mitochondria

Greenamyre, J. T., Betarbet, R. S., & Sherer, T. (2003) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(03)00023-3 · Cited by 257 · see citing works

Coenzyme Q10 attenuates the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) induced loss of striatal dopamine and dopaminergic axons in aged mice

Beal, M. F., Matthews, R. T., Tieleman, A., & Shults, C. W. (1998) · Brain Research · doi:10.1016/s0006-8993(97)01192-x · Cited by 256 · see citing works

Mitochondrial dysfunction in the limelight of Parkinson's disease pathogenesis

Banerjee, R., Starkov, A. A., Beal, M. F., & Thomas, B. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.11.007 · Cited by 256 · see citing works

Glutathione Depletion in PC12 Results in Selective Inhibition of Mitochondrial Complex I Activity

Jha, N., Jurma, O. P., Lalli, G., Liu, Y., Pettus, E. H., Greenamyre, J. T., Liu, R.-M., Forman, H. J., & Andersen, J. K. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000120200 · Cited by 252 · see citing works

Alternative Mitochondrial Electron Transfer as a Novel Strategy for Neuroprotection

Wen, Y., Li, W., Poteet, E. C., Xie, L., Tan, C., Yan, L., Ju, X., Liu, R., Qian, H., Marvin, M. A., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.208447 · Cited by 251 · see citing works

Etiology of Parkinson’s disease

Schapira, A. H. V. (2006) · Neurology · doi:10.1212/wnl.66.10_suppl_4.s10 · Cited by 251 · see citing works

Dietary Antioxidants and Parkinson Disease

de Rijk, M. C. (1997) · Archives of Neurology · doi:10.1001/archneur.1997.00550180070015 · Cited by 250 · see citing works

Mitochondrial dysfunction in Parkinson's disease

Greenamyre, J. T., MacKenzie, G. M., Peng, T., & Stephans, S. E. (1999) · Biochemical Society Symposia · doi:10.1042/bss0660085 · Cited by 248 · see citing works

The many roads to mitochondrial dysfunction in neuroimmune and neuropsychiatric disorders

Morris, G., & Berk, M. (2015) · BMC Medicine · doi:10.1186/s12916-015-0310-y · Cited by 245 · see citing works

Manganese ethylene‐bis‐dithiocarbamate and selective dopaminergic neurodegeneration in rat: a link through mitochondrial dysfunction

Zhang, J., Fitsanakis, V. A., Gu, G., Jing, D., Ao, M., Amarnath, V., & Montine, T. J. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01525.x · Cited by 238 · see citing works

Mitochondrial complex I and IV activities in leukocytes from patients with parkin mutations

Müftüoğlu, M., Elibol, B., Dalmızrak, Ö., Ercan, A., Kulaksiz-Erkmen, G., Öğüş, İ. H., Dalkara, T., & Özer, N. (2003) · Movement Disorders · doi:10.1002/mds.10695 · Cited by 237 · see citing works

Bioenergetic approaches for neuroprotection in Parkinson's disease

Beal, M. F. (2003) · Annals of Neurology · doi:10.1002/ana.10479 · Cited by 236 · see citing works

Multivariate meta-analyses of mitochondrial complex I and IV in major depressive disorder, bipolar disorder, schizophrenia, Alzheimer disease, and Parkinson disease

Holper, L., Ben‐Shachar, D., & Mann, J. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0090-0 · Cited by 234 · see citing works

Behavioral and immunohistochemical effects of chronic intravenous and subcutaneous infusions of varying doses of rotenone

Fleming, S. M. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2004.01.023 · Cited by 230 · see citing works

Proteomic Identification of a Stress Protein, Mortalin/mthsp70/GRP75

Jin, J., Hulette, C., Wang, Y., Zhang, T., Pan, C., Wadhwa, R., & Zhang, J. (2006) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m500382-mcp200 · Cited by 228 · see citing works

The role of Coenzyme Q in mitochondrial electron transport

Lenaz, G., Fato, R., Formiggini, G., & Genova, M. L. (2007) · Mitochondrion · doi:10.1016/j.mito.2007.03.009 · Cited by 224 · see citing works

NF-κB-Mediated Neuroinflammation in Parkinson’s Disease and Potential Therapeutic Effect of Polyphenols

Singh, S. S., Nand, S., Birla, H., Zahra, W., Singh, S. P., & Singh, S. P. (2019) · Neurotoxicity Research · doi:10.1007/s12640-019-00147-2 · Cited by 215 · see citing works

Apoptotic signaling in dopamine‐induced cell death: the role of oxidative stress, p38 mitogen‐activated protein kinase, cytochrome c and caspases

Junn, E., & Mouradian, M. M. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00425.x · Cited by 214 · see citing works

Pesticides and Parkinson's disease

Couteur, D. G. L., McLean, A. J., Taylor, M. C., Woodham, B. L., & Philip G. Board (1999) · Biomedicine & Pharmacotherapy · doi:10.1016/s0753-3322(99)80077-8 · Cited by 212 · see citing works

Glutathione and Parkinson's disease: Is this the elephant in the room?

Zeevalk, G. D., Razmpour, R., & Bernard, L. P. (2008) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2008.01.017 · Cited by 209 · see citing works

Mitochondrial dysfunction in neurodegenerative disorders

Schapira, A. H. V. (1998) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/s0005-2728(98)00115-7 · Cited by 210 · see citing works

Role of Platelet Mitochondria: Life in a Nucleus-Free Zone

Melchinger, H., Jain, K., Tyagi, T., & Hwa, J. (2019) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2019.00153 · Cited by 208 · see citing works

Coenzyme Q10 supplementation provides mild symptomatic benefit in patients with Parkinson's disease

Müller, T. H., Büttner, T., Gholipour, A.-F., & Kuhn, W. (2003) · Neuroscience Letters · doi:10.1016/s0304-3940(03)00185-x · Cited by 203 · see citing works

Metabolic profiling of Parkinson's disease: evidence of biomarker from gene expression analysis and rapid neural network detection

Ahmed, S. S. S. J., Santosh, W., Kumar, S., & Christlet, H. T. T. (2009) · Journal of Biomedical Science · doi:10.1186/1423-0127-16-63 · Cited by 197 · see citing works

Mitochondrial Quality Control in Neurodegenerative Diseases: Focus on Parkinson's Disease and Huntington's Disease

Franco-Iborra, S., Vila, M., & Perier, C. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00342 · Cited by 194 · see citing works

Coenzyme Q10 effects in neurodegenerative disease

Henchcliffe, C. (2009) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s5212 · Cited by 188 · see citing works

Mitochondria mass is low in mouse substantia nigra dopamine neurons: Implications for Parkinson's disease

Liang, C., Wang, T. T., Luby‐Phelps, K., & German, D. C. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2006.08.015 · Cited by 186 · see citing works

Platelet mitochondrial function: from regulation of thrombosis to biomarker of disease.

Zharikov, S. I., & Shiva, S. (2013) · Biochemical Society Transactions · doi:10.1042/bst20120327 · Cited by 182 · see citing works

Genes, proteins, and neurotoxins involved in Parkinson’s disease

Halbach, O. V. B. U., Schober, A., & KRIEGLSTEIN, K. G. (2004) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2004.05.002 · Cited by 178 · see citing works

Central pathways causing fatigue in neuro-inflammatory and autoimmune illnesses

Morris, G., Berk, M., Walder, K. R., & Maes, M. H. J. (2015) · BMC Medicine · doi:10.1186/s12916-014-0259-2 · Cited by 179 · see citing works

Mitochondrial Dysfunction in Parkinson's Disease

Keane, P. C., Kurzawa‐Akanbi, M., Blain, P. G., & Morris, C. M. (2011) · Parkinson s Disease · doi:10.4061/2011/716871 · Cited by 177 · see citing works

Mitochondrial dysfunction in Parkinson's disease

Schapira, A. H. V. (2007) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402160 · Cited by 175 · see citing works

Autism Associated With the Mitochondrial DNA G8363A Transfer RNALys Mutation

Graf, W. D., Marı́n-Garcı́a, J., Gao, H.-G., Pizzo, S., Naviaux, R. K., Markusic, D. M., Barshop, B. A., Courchesne, E., & Haas, R. (2000) · Journal of Child Neurology · doi:10.1177/088307380001500601 · Cited by 174 · see citing works

Mitochondria Targeted Peptides Protect Against 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Neurotoxicity

Yang, L., Zhao, K., Calingasan, N. Y., Luo, G., Szeto, H. H., & Beal, M. F. (2009) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2445 · Cited by 169 · see citing works

Mitochondria, OxPhos, and neurodegeneration: cells are not just running out of gas

Área-Gómez, E., Guardia‐Laguarta, C., Schon, E. A., & Przedborski, S. (2019) · Journal of Clinical Investigation · doi:10.1172/jci120848 · Cited by 169 · see citing works

Human complex I defects in neurodegenerative diseases

Schapira, A. H. V. (1998) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/s0005-2728(98)00032-2 · Cited by 166 · see citing works

Understanding the susceptibility of dopamine neurons to mitochondrial stressors in Parkinson's disease

Haddad, D., & Nakamura, K. (2015) · FEBS Letters · doi:10.1016/j.febslet.2015.10.021 · Cited by 162 · see citing works

Mitochondrial Dysfunction in Parkinson's Disease

Zhu, J., & Chu, C. T. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100363 · Cited by 158 · see citing works

Dopamine‐Induced Apoptosis Is Mediated by Oxidative Stress and Is Enhanced by Cyanide in Differentiated PC12 Cells

Jones, D. C., Gunasekar, P. G., Borowitz, J. L., & Isom, G. E. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0742296.x · Cited by 156 · see citing works

Estrogen actions on mitochondria—Physiological and pathological implications

Simpkins, J. W., Yang, S., Sarkar, S. N., & Pearce, V. P. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.04.013 · Cited by 158 · see citing works

A Synopsis on the Role of Tyrosine Hydroxylase in Parkinson’s Disease

Tabrez, S. S. M., Jabir, N. R., Shakil, S., Greig, N. H., Alam, Q., Abuzenadah, A. M., Damanhouri, G., & Kamal, M. A. (2012) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152712800792785 · Cited by 152 · see citing works

PPAR: a therapeutic target in Parkinson’s disease

Chaturvedi, R. K., & Beal, M. F. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05388.x · Cited by 147 · see citing works

Local Melatoninergic System as the Protector of Skin Integrity

Slominski, A. T., Kleszczyński, K., Semak, I. V., Janjetović, Z., Zmijewski, M. A., Kim, T., Slominski, R. M., Reiter, R. J., & Fischer, T. W. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms151017705 · Cited by 145 · see citing works

Mitochondrial mechanisms of estrogen neuroprotection

Simpkins, J. W., & Dykens, J. A. (2007) · Brain Research Reviews · doi:10.1016/j.brainresrev.2007.04.007 · Cited by 145 · see citing works

NRF2 Activation Restores Disease Related Metabolic Deficiencies in Olfactory Neurosphere-Derived Cells from Patients with Sporadic Parkinson's Disease

Cook, A. L., Vitale, A. M., Ravishankar, S., Matigian, N., Sutherland, G. T., Shan, J., Sutharsan, R., Perry, C., Silburn, P. A., Mellick, G. D., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021907 · Cited by 143 · see citing works

Acetyl-l-carnitine and α-lipoic acid affect rotenone-induced damage in nigral dopaminergic neurons of rat brain, implication for Parkinson's disease therapy

Zaitone, S. A., Abo–Elmatty, D. M., & Shaalan, A. A. M. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.09.002 · Cited by 141 · see citing works

Mitochondrial dynamics in Parkinson's disease

Laar, V. S. V., & Berman, S. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.03.019 · Cited by 139 · see citing works

High frequency of mitochondrial complex I mutations in Parkinson’s disease and aging

Smigrodzki, R. M., Parks, J. K., & Parker, W. D. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.02.020 · Cited by 138 · see citing works

M itochondrial DNA and primary mitochondrial dysfunction in P arkinson's disease

Giannoccaro, M. P., Morgia, C. L., Rizzo, G., & Carelli, V. (2017) · Movement Disorders · doi:10.1002/mds.26966 · Cited by 134 · see citing works

The transcription factor Nrf2 as a new therapeutic target in Parkinson's disease

Cuadrado, A., Moreno-Murciano, P., & Pedraza‐Chaverrí, J. (2009) · Expert Opinion on Therapeutic Targets · doi:10.1517/13543780802716501 · Cited by 135 · see citing works

Contribution of the Nrf2 Pathway on Oxidative Damage and Mitochondrial Failure in Parkinson and Alzheimer’s Disease

Villavicencio-Tejo, F., & Quintanilla, R. A. (2021) · Antioxidants · doi:10.3390/antiox10071069 · Cited by 135 · see citing works

Regulation of SIRT3 on mitochondrial functions and oxidative stress in Parkinson’s disease

Shen, Y., Wu, Q., Shi, J., & Zhou, S. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110928 · Cited by 132 · see citing works

Proteasomal inhibition induced by manganese ethylene-bis-dithiocarbamate: Relevance to parkinson′s disease

Zhou, Y. F., Shie, F., Piccardo, P., Montine, T. J., & Zhang, J. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.06.048 · Cited by 132 · see citing works

The interplay of neuronal mitochondrial dynamics and bioenergetics: Implications for Parkinson's disease

Laar, V. S. V., & Berman, S. B. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.05.015 · Cited by 133 · see citing works

Targeting urate to reduce oxidative stress in Parkinson disease

Crotty, G. F., Ascherio, A., & Schwarzschild, M. A. (2017) · Experimental Neurology · doi:10.1016/j.expneurol.2017.06.017 · Cited by 130 · see citing works

Quantitative proteomic analysis of mitochondrial proteins: relevance to Lewy body formation and Parkinson's disease

Jin, J., Meredith, G. E., Chen, L., Zhou, Y. F., Xu, J., Shie, F., Lockhart, P. J., & Zhang, J. (2004) · Molecular Brain Research · doi:10.1016/j.molbrainres.2004.10.003 · Cited by 129 · see citing works

Mitochondrial toxins in models of neurodegenerative diseases. I: in vivo brain hydroxyl radical production during sytemic MPTP treatment or following microdialysis infusion of methylpyridinium or azide ions

Smith, T. S., & Bennett, J. P. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00429-0 · Cited by 129 · see citing works

CoQ10 and Aging

de Barcelos, I. P., & Haas, R. (2019) · Biology · doi:10.3390/biology8020028 · Cited by 126 · see citing works

Complex I: Inhibitors, inhibition and neurodegeneration

Schapira, A. H. V. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2010.03.028 · Cited by 125 · see citing works

Glucose Metabolic Dysfunction in Neurodegenerative Diseases—New Mechanistic Insights and the Potential of Hypoxia as a Prospective Therapy Targeting Metabolic Reprogramming

Han, R., Liang, J., & Zhou, B. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115887 · Cited by 125 · see citing works

Urinary 8-hydroxydeoxyguanosine levels as a biomarker for progression of Parkinson disease

Sato, S., Mizuno, Y., & Hattori, N. (2005) · Neurology · doi:10.1212/01.wnl.0000154597.24838.6b · Cited by 124 · see citing works

Preferentially Increased Nitration of α-Synuclein at Tyrosine-39 in a Cellular Oxidative Model of Parkinson’s Disease

Danielson, S. R., Held, J. M., Schilling, B., Oo, M. L., Gibson, B. W., & Andersen, J. K. (2009) · Analytical Chemistry · doi:10.1021/ac901176t · Cited by 123 · see citing works

Differential Cytotoxicity of Mn(II) and Mn(III): Special Reference to Mitochondrial [Fe-S] Containing Enzymes

Chen, J., Tsao, G. C., Zhao, Q., & Zheng, W. (2001) · Toxicology and Applied Pharmacology · doi:10.1006/taap.2001.9245 · Cited by 123 · see citing works

Mitochondrial DNA Deletions/Rearrangements in Parkinson Disease and Related Neurodegenerative Disorders

Gu, G., Reyes, P. F., Golden, G. T., Woltjer, R. L., Hulette, C., Montine, T. J., & Zhang, J. (2002) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/61.7.634 · Cited by 122 · see citing works

Oxidative α-Ketoglutarate Dehydrogenase Inhibition via Subtle Elevations in Monoamine Oxidase B Levels Results in Loss of Spare Respiratory Capacity

Kumar, M. J., Nicholls, D. G., & Andersen, J. K. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306378200 · Cited by 120 · see citing works

Electron transfer complexes I and IV of platelets are abnormal in Parkinson's disease but normal in Parkinson-plus syndromes

Benecke, R., Strumper, P., & Weiss, H. (1993) · Brain · doi:10.1093/brain/116.6.1451 · Cited by 220 · see citing works

Abnormalities of the electron transport chain in idiopathic parkinson's disease

Parker, W. D., Boyson, S. J., & Parks, J. K. (1989) · Annals of Neurology · doi:10.1002/ana.410260606 · Cited by 1,061 · see citing works

Mitochondrial complex I and II activities of lymphocytes and platelets in Parkinson's disease

Yoshino, H., Nakagawa-Hattori, Y., Kondo, T., & Mizuno, Y. (1992) · Journal of Neural Transmission - Parkinsons Disease and Dementia Section · doi:10.1007/bf02257619 · Cited by 195 · see citing works

Platelet mitochondrial activity and pesticide exposure in early Parkinson's disease

Bronstein, J. M., Paul, K. C., Yang, L., Haas, R., Shults, C. W., Le, T. P., & Ritz, B. R. (2015) · Movement Disorders · doi:10.1002/mds.26164 · Cited by 18 · see citing works

PLATELET MITOCHONDRIAL-FUNCTION IN PARKINSONS-DISEASE

Krige, D., CARROLL, M., Cooper, J. A. D., MARSDEN, C., & Schapira, A. H. V. (1992) · UCL Discovery (University College London) · Cited by 12 · see citing works